United States & Regeneron Pharmaceuticals
5 shared events · Importance 3 · Last updated Jun 03, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Tech
Regeneron Pharmaceuticals: Regeneron Pharmaceuticals partly funds and supports Atara Biotherapeutics in developing therapies for diseases like inflammatory bowel disease, leveraging the Nobel-winning research.
Oct 06, 2025 · 6 articles
Regulatory
Regeneron Pharmaceuticals: Regeneron Pharmaceuticals is expected to announce a deal with the Donald Trump administration after the holidays.
Dec 19, 2025 · 7 articles
Business
Regeneron Pharmaceuticals: Regeneron Pharmaceuticals, in collaboration with Sanofi, developed Dupixent and received regulatory approvals for new indications, which is expected to positively impact its revenue and market position.
Feb 24, 2026 · 8 articles
Business
Regeneron Pharmaceuticals: Regeneron Pharmaceuticals, in collaboration with Sanofi, developed Dupixent and received International — European Commission approval for its use in treating chronic spontaneous urticaria in young children, which is expected to boost its market position and revenue.
Apr 13, 2026 · 8 articles
NEWSDESK
Explore this relationship live
Track how United States and Regeneron Pharmaceuticals interact across events, view sentiment trends, and discover connected entities.
Open Dashboard